MedCity News
SEPTEMBER 24, 2023
Syntax Bio’s technology platform uses CRISPR to direct stem cells to become a desired cell type in a process that’s more scalable and less expensive than current methods. The startup is raising a Series A round of financing to further demonstrate the potential of its technology.
PharmaTech
SEPTEMBER 24, 2023
Jet milling is a well-established particle engineering technique for producing micronized powders with controlled particle size distribution and increased surface area. This makes them suitable for inhalation drug delivery. However, successful implementation of jet milling requires a robust Quality by Design (QbD) approach that ensures the critical quality attributes of the micronized particles are maintained throughout the process development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
SEPTEMBER 24, 2023
There are concerns that Medicare Advantage TV ads are misleading patients. A new KFF analysis of Medicare Advantage TV ads found that the ads often rely on celebrity endorsements and suggest that seniors are missing out on benefits that they’re entitled to.
PharmExec
SEPTEMBER 24, 2023
Via Nova Therapeutics’ VNT-101 is an Influenza A nucleoprotein inhibitor.
MedCity News
SEPTEMBER 24, 2023
As value-based care models take hold, the time is ripe for rehab therapists to position themselves as primary players in the movement toward delivering optimal quality and value in the broader healthcare ecosystem.
PharmExec
SEPTEMBER 24, 2023
The device, Maverick, utilizes Raman spectroscopy for bioprocess control.
Expert insights. Personalized for you.
127 
Let's personalize your content